All About SCA6
SCA6 or Spinocerebellar Ataxia 6 is a rare neuromuscular disease. The National Ataxia Foundation is proud to host this webinar presented by Dr. Anoopum Gupta on April 10, 2023. In "All About SCA6", he gave an overview of the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care. For more information on SCA6, register for our next webinar on Research and Treatment Development for SCA6 on April 26th at 12 pm CDT: https://us02web.zoom.us/webinar/regis... For more information on Ataxia, please visit our website: https://www.ataxia.org Become a Free NAF member! https://bit.ly/JoinNAF Follow us on Social Media! NAF Facebook: / ataxiafounda. . NAF Twitter: / naf_ataxia NAF Instagram: / ataxiafound. . Ataxia Subreddit: / ataxia About the Speaker: Anoopum Gupta, MD, PhD, received his undergraduate degree in Electrical Engineering from Georgia Tech, his medical degree from the University of Pittsburgh School of Medicine, and his PhD in Robotics from Carnegie Mellon University’s School of Computer Science. He completed his residency in neurology at the Mass General Brigham-Harvard Neurology Residency Program (Mass General and Brigham and Women’s Hospital). His clinical interests are in neurogenetic and neurodegenerative diseases, including cerebellar ataxias, Parkinson’s disease, atypical parkinsonian disorders, and Huntington’s disease. His research program involves the use of accessible technologies combined with signal processing, computer vision, and machine learning methods to deeply understand how neurodegenerative diseases impact motor and cognitive behavior. Broadly he is involved in research at the intersection of computational science and medicine. About the Series: NAF is producing a series of monthly educational webinars that focus on one type of Ataxia at a time. Each month we will feature a different type. Clinical experts will join us to take a look at the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care. Research experts will teach us how the disease is studied and give an overview of the current state of research and drug development.
